Openbookopenbook
Equity
Otsuka Holdings Co Ltd ADR(OTSKY)
USD --+0.00%
Reward70High
Risk19Low
📊75%Data
OTSKY
+0.0 · +0.00%
USD · PINK
Otsuka Holdings Co Ltd ADR | Healthcare
Quality Compounder
Market Cap:36.61Bn
ℹ️
Reward Rating
70
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
19
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on OTSKY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $36.70.

What is Otsuka Holdings Co Ltd ADR?

engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

OTSKY · Verdict

Strong reward · low risk

OTSKY scores well on valuation and profitability with no major weaknesses flagged in the model.

Based on 88% data coverage

OTSKY · Verdict

What’s working & what to watch

Strengths 6

  • Valuation90/100

    P/E 14.0×

  • Profitability86/100

    15% net margin · 12% ROE

  • Balance sheet85/100

    Interest covered 15.3×

  • Cash flow82/100

    13% free-cash-flow margin

  • Volatility75/100

    Above average

  • Growth66/100

    Rev +14.2% CAGR · earnings +41.7%

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Otsuka Holdings Co Ltd ADR?

engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 36.61B, and a P/E ratio of 15.2x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: High (70)

The scoring profile indicates a strong reward potential, driven primarily by valuation and profitability. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap36.61B
P/E Ratio15.1946
Dividend Yield1.30%
52 Week High34.9288
52 Week Low21.3053
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding1B
No. of Employees35,338
IndustryDrug Manufacturers - General
ExchangePINK
Beta-0.125
CurrencyUSD
Websitewww.otsuka.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.